Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Solas Capital Management, LLC reported a 8.20% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Solas Capital Management, LLC reported a 8.20% stake in Fennec Pharmaceuticals Inc., 2,250,919 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
8.20%
Shares
2,250,919
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Solas Capital Management, LLC8.20%2,250,919
FREDERICK TUCKER GOLDEN8.20%2,250,919

Source

View original at SEC

Related